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Background 
Psychotic symptoms and psychotic disorders occur at increased rates in adults with 
intellectual disability, including borderline intellectual functioning, compared to the 
general population.  Little is known about the development of such symptoms in this 
population.     
 
Aims 
To examine whether clinical factors predictive of psychotic disorder in a familial 
study of schizophrenia, also apply to those with intellectual impairment. 
 
Method 
Adolescents with special educational needs (SEN) were assessed using the Structured 
Interview for Schizotypy (SIS) and Childhood Behaviour Checklist (CBCL).  These 
scores were used to prospectively divide participants based on their anticipated risk 
for psychotic disorder.  A sub-sample were re-assessed three times over six years 
using the Positive and Negative Syndrome Scale (PANSS).   
 
Results 
The SEN group were more symptomatic than controls throughout (Cohens d range for 
PANSS subscale scores: 0.54–1.4, all P<0.007).  Over 6 years follow-up, those above 
the SIS and CBCL cut-offs at baseline were more likely than those below to display 
morbid positive psychotic symptoms (OR=3.5, 95% CI=1.3-9.0) and develop 
psychotic disorder (OR=11.4, 95% CI=2.6-50.1).  Baseline SIS and CBCL cut-offs 
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predicted psychotic disorder with sensitivity of 0.67, specificity of 0.85, positive 
predictive value of 0.26 and negative predictive value of 0.97.   
 
Conclusions 
Adolescents with SEN have increased psychotic and non-psychotic symptoms.  The 
personality and behavioural features associated with later psychotic disorder in this 
group are similar to those in people with familial loading.  Relatively simple 
screening measures may help to identify those in this vulnerable group who do and do 
not require monitoring for psychotic symptoms.    
 
Declaration of Interest 
None 
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INTRODUCTION 
 
Individuals with intellectual disability are known to have higher rates of 
psychopathology than the general population (1, 2).  In particular, it is well 
established they show a three- to five-fold increase in the prevalence of schizophrenia 
(3-6).  This increase in risk for psychosis has also recently been extended to those 
with borderline intellectual functioning (i.e. IQ between 70 and 85), who have been 
reported to have over twice the risk of developing a probable psychosis compared to 
those of higher IQ (7).  Despite these findings, there is a relative paucity of research 
on the early development of psychotic symptoms in the intellectually impaired, with 
studies more commonly focusing on groups at increased risk due to familial reasons 
(8) or the presence of prodromal symptoms (9).    
 
The Edinburgh Study of Comorbidity (ESC) was initially set-up in 2005 to 
longitudinally examine a group of young people at enhanced risk for later 
schizophrenia due to intellectual impairment (10).  The ESC was stimulated by earlier 
work on the Edinburgh High Risk Study (EHRS) of people at familial risk of 
developing schizophrenia (8); essentially the aim was to examine the extent to which 
the findings of the EHRS were replicated in an investigation where the heavy familial 
loading was not present.  To this end, the cohort recruited for the ESC was not 
derived from health services, but instead was acquired from education services, on the 
basis that they were receiving special educational support for presumed intellectual 
impairment.   
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Within the ESC cohort, we have previously demonstrated that, at baseline, high levels 
of schizotypal traits were associated with clinical, neuropsychological and brain 
structural features that are consistent with findings from the EHRS (10-12).  We have 
also reported that those with the highest levels of schizotypal traits and adolescent 
behavior difficulties were most likely to develop psychotic symptoms over the first 2 
years of follow-up (10) and that these individuals showed increased levels of medial 
temporal lobe volume loss over this time (13).  More recently we extended these brain 
structural findings to 6 years of follow-up, into early adulthood, where we found that 
those with high levels of psychotic symptoms continue to show medial temporal lobe 
grey matter loss over this time (14) and that the presence of negative symptoms is also 
associated with longitudinal gray matter tissue loss in other brain regions (15).   
 
The current paper concerns the clinical findings derived from the 6-year follow-up 
study of these young people with special educational needs.  Specifically, we had two 
primary aims: i) to determine the level of psychiatric symptomatology in this cohort 
through adolescence and early adulthood; and ii) to examine the predictors of the 
development of psychotic symptoms, and of psychotic disorder.  With regard to our 
first aim and based on previous work examining psychopathology in adults with 
borderline and mild intellectual disabilities (1, 7) we hypothesized that those 
receiving educational assistance would have higher rates of psychopathology than 
controls at all three time points.  For the second aim, in the light of our previous 
findings from the early follow-up of this cohort (10) and from the EHRS (8), we 
hypothesized that later psychotic symptoms, and indeed psychotic disorder, would be 
predicted by the combined presence of high levels of baseline schizotypal features 
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and behavioural difficulties, as well as other known risk factors for psychosis, such as 
obstetric complications, substance misuse and family history. 
 
METHODS 
 
Participant Recruitment and Baseline Assessment 
Ethical approval for the study was granted by the Multicentre Research Ethics 
Committee for Scotland. Full details of recruitment are available elsewhere (10) and 
are summarized in Figure 1.  Briefly, relevant schools and colleges throughout 
mainland Scotland were contacted and asked to identify young people, aged 13-22 
years, receiving educational assistance for presumed intellectual impairment and with 
an estimated IQ of between 50 and 80 (as IQ is not routinely measured in the Scottish 
educational system).  After exclusions, 394 individuals with special educational needs 
(SEN) were recruited to undergo further investigations.   
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Figure 1 
 
At their initial assessment these participants were assessed with the Structured 
Interview for Schizotypy (SIS) (16) and the Childhood Behavioural Checklist 
(CBCL) (17). Cut-offs on these instruments had been found to predict the later 
development of schizophrenia in the Edinburgh High Risk Study (EHRS) of 
3146 families with children receiving special 
educational assistance 
501 participants consented for initial screening 
394 participants screened using SIS and CBCL  
107 exclusions due to: 
Consent withdrawn / no contact established (65) 
Age (9) 
Severe cerebral palsy (9)  
Severe intellectual disability or non-verbal (12) 
Known traumatic brain injury (5) 
Down Syndrome (7) 
SISlow CBCLlow 
N=200  
SIShighCBCLlow 
N=106 
SISlowCBCLhigh 
N=52 
SIShighCBCLhigh  
N=36  
SISlow CBCLlow 
N=42 
SIShighCBCLlow 
N=55 
SISlowCBCLhigh 
N=39 
SIShighCBCLhigh  
N=32 
SISlow CBCLlow 
N=34 
SIShighCBCLlow 
N=45 
SISlowCBCLhigh 
N=20 
SIShighCBCLhigh  
N=23 
SISlow CBCLlow 
N=15 
SIShighCBCLlow 
N=23 
SISlowCBCLhigh 
N=7 
SIShighCBCLhigh  
N=11 
SISlow CBCLlow 
N=35 
SIShighCBCLlow 
N=45 
SISlowCBCLhigh 
N=20 
SIShighCBCLhigh  
N=23 
Baseline 
Assessment 
Participants 
with 2 or 
more 
assessments 
 
 
 
 
Time point 1 
Time point 2 
Time point 3 
Screening / 
recruitment 
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individuals at enhanced familial risk of schizophrenia (8) and therefore these were 
used to derive cut-offs for the ESC in order to create 4 cells of individuals: those with 
high scores on both SIS and CBCL (SIShighCBCLhigh), those with low scores on both 
(SISlowCBCLlow) and those with high on one and low on the other (SIShighCBCLlow 
and SISlowCBCLhigh).  These SIS / CBCL groupings were then sampled with the 
intention of conducting detailed assessments on approximately equal numbers of 
individuals from each group.  This left a final population for study of 168 individuals.  
It is important to note that this sampling deliberately led to a relative enrichment of 
individuals scoring high on these scales (see Figure 1).  
 
In addition, two comparison groups comprising typically developing siblings (also in 
the 13-22 age group) and age-matched young people with no history of psychiatric 
disorder or special educational requirement recruited through youth organizations in 
the areas from which the sample participants came. Basic demographic data, reported 
diagnoses (if any) and family history of psychiatric or neurodevelopmental disorders 
were also obtained at this time.  Family history was considered in four categories: 
psychotic illness, non-psychotic psychiatric illness, epilepsy and intellectual 
disability, and no family history. 
 
Assessments 
Approximately 6 months following this baseline assessment, participants were then 
examined using the semi-structured Clinical Interview Schedule (CIS) (18) and the 
Positive and Negative Syndrome Scale (PANSS) (19).  These assessments of 
psychopathology were conducted by clinicians blinded to group membership of 
participants.   Inter-rater reliabilities were conducted for the CIS and were greater 
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than 0.76 (10).  IQ was formally measured at this time using either the Wechsler 
Adult Intelligence Scale, 3rd edition (WAIS) or the Wechsler Intelligence Scale for 
Children, 3rd edition (WISC) as appropriate (20, 21).  In addition, participants also 
underwent a structural MRI scan and neuropsychological assessments of executive 
function and memory, though these are not considered further in the current paper.  
All of these assessments were conducted by staff who had not been involved in the 
initial assessments using the SIS and CBCL and who were therefore blind to their 
ratings on these instruments.  
 
The CIS, PANSS, MRI and neuropsychological assessments were repeated 1-2 years 
later and again 6 years later in all participants who consented to be followed-up, 
although on the last occasion, no attempt was made to reassess the sibling controls.  
Information on substance misuse was collected only for those who returned after 6 
years.     
 
Participants and their mothers were also asked to give consent for the examination of 
their obstetric and neonatal histories from routinely collected healthcare data held by 
the Information and Statistics Division of the National Health Service in Scotland.  
Full details of the data extracted and the linkage process are given elsewhere (22).  
For the present study, data on gestational age at birth, weight at birth, occiptofrontal 
circumference and Apgar scores were examined.    
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Statistical Analysis 
 
As the present study concerns the possible predictors of psychotic symptomatology, 
only participants who had provided data for interview on at least two of the three 
assessment points were included.  The related controls were not included as they were 
not assessed at the final time point.   
 
In order to examine the psychopathology in all participants, PANSS subscale scores at 
each successive time point were compared between controls and the SEN group, 
initially as a whole and then divided by SIS/CBCL grouping.  As the PANSS scores 
were not normally distributed Kruskal-Wallis tests and Mann-Whitney U-tests were 
employed for these analyses.   
 
The next step aimed to establish whether factors found to predict psychosis in the 
familial EHRS, were also associated with the development of psychotic symptoms in 
the current cohort.  The identification of psychotic symptoms can be more difficult to 
make with confidence in those with intellectual disability (23); this is particularly the 
case for  negative symptoms such as poverty of speech or flattening of affect, but also 
for certain positive symptoms such as conceptual disorganization.  With this in mind a 
conservative approach was adopted, only considering participants as having psychotic 
symptoms if they showed clear evidence of either delusions or hallucinations (which 
according to PANSS criteria relates to a score of 3 or more in relevant items) at one or 
more time points throughout the study.  This is consistent with our previous approach 
in this cohort (14).  Using these criteria, participants were therefore divided into 2 
groups: ‘psychotic symptoms present’ and psychotic symptoms absent’.  The 
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relationship between psychotic symptom status and SIS / CBCL grouping was then 
examined using chi-squared tests and an odds ratio calculated comparing those who 
scored above cut-off on both instruments versus the remainder of the population.  
Next the relationship between symptom status and the other potential predictors of 
interest (IQ, family history, obstetric complications and substance misuse) were 
examined by comparing the groups using t-tests, chi-squared tests or Mann-Whitney 
U-tests as appropriate to the distribution of the data.   
 
While the above analyses examine the relationship between psychotic symptoms and 
potential predictors, one of the primary intentions of the study was to consider 
whether the SIS / CBCL groupings would be helpful in predicting the development of 
a psychotic disorder, not just symptoms.  In order to examine this, a final analysis was 
conducted where the SEN group was dichotomised into those with a likely psychotic 
disorder, based on scoring 4 or more on the delusions or hallucinations items of the 
PANSS, and those without.  A chi-squared test was then used to determine the 
relationship between SIS / CBCL grouping and future diagnostic status; sensitivity 
and specificity, as well as positive and negative predictive values, were also 
calculated for the SIS / CBCL groupings.   
 
 
RESULTS 
 
Participant characteristics and psychopathology  
The characteristics of the cohort at each time point are shown in Table 1.  Of the 168 
participants assessed at time point 1, 122 returned for time point 2, and 56 returned 
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for time point 3.  The reasons for the attrition between time point 2 and 3 related 
primarily to the recontact process required for the 6 year follow-up which occurred 
via participants’ General Practitioners (14).  To summarise, of those seen at the 
second time point: 3 participants did not give permission for future contact, 15 
participants were uncontactable, 23 participants no longer wished to be involved, and 
26 participants did not wish or were not able to return for full face-to-face 
assessments.  In addition, one participant attended for time point 3 who did not attend 
for time point 2.  There were no significant differences in baseline SIS/CBCL group 
membership between those who attended for all three time points and those who only 
attended at time points 1 and 2.   
 
There were no significant differences in age between the groups at any time point (all 
P>0.10); however, gender differed significantly between the SEN group and the 
controls at times 1 and 2 (both P=0.04), but not at time 3 (P=1.0).    
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The SEN group scored more highly than the controls on all subscales of the PANSS at 
each time point throughout the study (See Table 1, Cohen’s d effect sizes ranging 
from 0.54 to 1.4; all P<0.007).  This was the case regardless of whether the SEN 
group had an IQ less than 70 or not (all P<0.03).  Within the SEN group, those with 
an IQ of less than 70 tended to score more highly on negative symptoms than those 
with an IQ of greater than 70, but this was only significant at time points 2 and 3 
(time point 1: Z=-1.54, P=0.12; time point 2: Z=-3.40, P=0.001; time point 3: Z=-
2.69, P=0.007).  For positive and general symptoms there were no significant 
differences within the SEN group at any time point between those with an IQ of less 
than 70 compared to those with higher IQ (all P>0.44).  Notably, ten participants in 
the study had IQs of 100 or over; no significant differences were found between these 
10 and the other participants in their SIS, CBCL or PANSS scores at any time point 
(all p>0.10). 
Table 1 Cohort and Control participant characteristics  
 
SEN, Special Educational Needs; M:F, male:female; PANSS, Positive and Negative 
Syndrome Scale; PANSS P, PANSS positive subscale score; PANSS N, PANSS negative 
subscale score; PANSS G, PANSS general subscale score. 
Age and IQ given as mean (SD); PANSS scores given as median (range) 
  
 Time 1 Time 2 Time 3 
! SEN Controls SEN Controls SEN Controls 
n 123 28 122 28 56 10 
Gender!(M:F) 79:44 12:16 78:44 12:16 39:17 7:3 
Age 15.8 (1.7) 16.4 (1.8) 17.1 (1.6) 17.7 (1.8) 22.2 (2.0) 22.5 (2.2) 
IQ!at!entry 74.4 (17.5) 107.5 (17.3) 74.5 (17.6) 107.5 (17.3) 77.6 (16.5) 111.1 (16.6) 
PANSS!P! 8 (7-21) 7 (7-10) 8 (7-16) 7 (7-8) 7 (7-19) 7 (7-7) 
PANSS!N! 11 (7-31) 7 (7-14) 13 (7-26) 7 (7-13) 11 (7-29) 7 (7-7) 
PANSS!G! 20 (16-44) 17 (16-23) 19 (16-39) 16 (16-21) 19 (16-49) 16 (16-21) 
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When the SEN group were divided into the SIS/CBCL groupings, the Kruskal-Wallis 
test showed significant differences for positive, negative and general subscale scores 
on the PANSS at all time points.  Follow-up Mann-Whitney U-tests revealed that the 
SEN participants had higher levels of negative symptoms and general 
psychopathology than the controls at all time points regardless of their SIS / CBCL 
group allocation (all P<0.02).  Positive symptoms were also higher in the SEN groups 
with SIS scores above cut-off (i.e. SIShighCBCLhigh and SIShighCBCLlow groups) at all 
time points; whereas the two groups that scored below cut-off on the SIS (i.e. the 
SISlowCBCLhigh and SISlowCBCLlow groups) did not show significantly greater 
positive symptoms than the controls at time point 1 and time point 3 (see Figure s1 in 
Supplementary Material).    
 
Detailed inspection of the individual PANSS symptoms showed that across the three 
time points the relative morbidity of the SEN group in terms of positive symptoms is 
primarily related to hallucinations and delusions; in terms of negative symptoms it 
relates to concrete thinking, flattening of affect, poor rapport and poverty of speech; 
and in terms of general symptoms relates to high levels of anxiety, depression, 
somatic concern, unusual thought content and preoccupation (see Figures s2-s4 in 
Supplementary Material).   
 
 
Factors associated with the development of positive psychotic symptoms 
The characteristics of the SEN groups determined by the presence or absence of 
positive psychotic symptoms are shown in Table 2.  There were no differences 
between the groups with regard to age, gender or IQ (all P>0.1).  The presence of 
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positive psychotic symptoms was significantly associated with baseline SIS / CBCL 
grouping (χ2 =7.94, P=0.047); with the SIShighCBCLhigh group showing enhanced risk 
compared to the remainder of the population (OR=3.48, 95% CI=1.34-9.02).   
 
 
Family history data were available on 106 participants in the SEN group.  Of these, 15 
individuals (14.2%) had a family history of a psychotic illness; 52 individuals 
(49.1%) had a family history of non-psychotic psychiatric disorder; 24 individuals 
(22.6%) had a family history of intellectual disability and 9 individuals (8.5%) had a 
family history of epilepsy.  Chi-squared tests showed that there were no significant 
relationships between any of the above family histories and the presence of positive 
psychotic symptoms (all P>0.08).   
Table 2: Characteristics of participants with SEN divided by the presence or absence of 
positive psychotic symptoms  
 Positive Symptoms Absent Positive Symptoms Present 
Age (time 1) 15.6 (1.4) 16.1 (2.0) 
Gender (M:F) 47:26 32:18 
IQ 72.5 (17.0) 77.2 (18.2) 
SIS / CBCL grouping 
        SISlowCBCLlow 
        SISlowCBCLhigh 
        SIShighCBCLlow 
        SIShighCBCLhigh 
 
24 (68.6%) 
14 (70%) 
27 (60.0%) 
8 (34.8%) 
 
11 (31.4%) 
6 (30%) 
18 (40.0%) 
15 (65.2%) 
 
Positive Symptoms Absent, Individuals who never scored more than 2 on PANSS delusions 
or hallucinations subscales.  Positive Symptoms Present: Individuals who scored 3 or more 
on PANSS delusions or hallucinations subscales at one or more time points throughout the 
study. SIS, Structured Interview for Schizotypy; CBCL, Childhood Behavioural Checklist.  
Age and IQ given as mean (SD).  
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Obstetric data were available on 91 participants in the SEN group.  No significant 
associations were found between the presence of positive psychotic symptoms and 
birth weight (t=-0.88, P=0.38), gestational age (t=-0.99, P=0.32), occipitofrontal 
circumference (t=-0.83, P=0.41), Apgar score at 1 minute (Z=-0.80, P=0.43) or Apgar 
score at 5 minutes (Z=-1.04, P=0.30).   
 
Data on illicit drug use were available for 54 of the 56 SEN participants who attended 
the third follow-up.  Of these, only 9 participants had ever used illicit drugs on more 
than 3 occasions.  There was no relationship between illicit drug use and the presence 
of psychotic symptoms (Fishers exact test, P=1.0).   
 
The development of psychotic disorder in the cohort 
Nine participants scored 4 or more on either the delusions of hallucinations subscales 
of the PANSS.  In seven of them, the symptoms were persistent and convincing and 
provide strong clinical justification for a diagnosis of definite or probable 
schizophrenia.  In the remaining two the diagnosis is less clear as the account given 
was limited, however, they did report persistent auditory hallucinations over a 
sustained period.  The distribution of these individuals with respect to the baseline 
SIS/CBCL groups is shown in Table 3.  The Fisher’s exact test demonstrated 
significant differences between the groups (P=0.003) with six of the nine participants 
being in the SIShighCBCLhigh group at baseline; with the SIShighCBCLhigh group 
showing significantly increased risk compared to the remainder of the population  
(OR=11.4, 95% CI= 2.6-50.1). 
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In terms of the 6-year prediction of psychotic disorder among individuals with special 
educational needs, using both the SIS and CBCL cut-offs provides the following 
values: sensitivity of 0.67, specificity of 0.85, positive predictive value of 0.26 and 
negative predictive value of 0.97.   
 
DISCUSSION 
In this non-clinical sample of young people who received special educational support, 
we found that the presence of schizotypal cognitions and behavioural difficulties in 
mid-adolescence was associated with the development of psychotic symptoms, and 
indeed likely schizophrenia, over the following six years.  These findings are in 
keeping with our original hypothesis, and are consistent with our previous study of 
individuals at risk of schizophrenia for familial reasons (8).   
 
Table 3: Distribution of psychotic participants among the baseline SIS/CBCL groupings 
 No psychotic disorder Psychotic disorder 
SISlowCBCLlow 35 (100%) 0 
SISlowCBCLhigh 19 (95%) 1 (5.0%) 
SIShighCBCLlow 43 (95.6%) 2 (4.4%) 
SIShighCBCLhigh 17 (73.9%) 6 (26.1%) 
 
No psychotic disorder, Individuals who never scored more than 3 on PANSS delusions or 
hallucinations subscales.  Psychotic disorder, Individuals who scored 4 or more on PANSS 
delusions or hallucinations subscales at one or more time points throughout the study.  SIS, 
Structured Interview for Schizotypy; CBCL, Childhood Behavioural Checklist. 
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Our findings suggest that the personality and behavioural features associated with the 
development of psychosis are the same regardless of whether the vulnerability state to 
psychosis is familial or intellectual in nature.  However, there are overlaps between 
the genetic risk factors for psychosis and cognitive impairment (24).  An alternative 
explanation of the concordance between the current study and the previous familial 
study is therefore that intellectual impairment in the current sample results from 
genetic factors overlapping those in our familial sample.  If that is the case then 
intellectual impairment may not be an independent vulnerability state to psychosis, 
instead the participants intellectual impairments could be regarded as resulting from a 
genetically determined schizophrenic process where the full symptoms of the disorder 
are yet to become manifest.  
 
It is evident from Table 3 that while most people who score above the SIS and CBCL 
cut-offs do not become unwell, a significant minority (26%) do develop a later 
psychotic disorder.  This is around 5-10 times higher than the reported rates in people 
with intellectual disability as whole (3-6).  Although this prevalence is high, the 
positive predictive value that we report is relatively low (0.26), highlighting that if 
these tests were applied widely, three out of four individuals would screen positive 
but would not go on to develop a psychotic disorder.  While such screening could be 
potentially useful to clinicians, the risk of harm to participants and their families must 
be considered and any screening carefully explained.  Perhaps of greater utility is the 
potential of these tests to exclude the risk of later psychotic disorder in this vulnerable 
population and this is reflected in the high negative predictive value that we report 
(0.97).  It is particularly notable that no-one in the SISlowCBCLlow group was found to 
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develop psychotic disorder across 6 years of study suggesting a very low risk in this 
group.   
 
We did not find any association between the presence of psychotic symptoms in those 
with special educational needs and the other potential predictors that we examined: 
obstetric factors, family history or substance misuse.  These findings were not 
expected given their previously identified associations with psychosis.  It is important 
to note that in the current study, rates of adverse obstetric factors were increased 
compared to the general population rates (22), a finding which is consistent with the 
established association between obstetric complications and intellectual disability 
(25).  This may explain why we did not observe the relatively specific association 
between obstetric complications and schizophrenia which has previously been 
reported in the general population.  It is possible that family history and substance 
misuse do not affect the likelihood of developing psychotic symptoms in this 
population, however, the group sizes for each were relatively small which may have 
affected our ability to detect any differences that were present.   
 
Beyond our initial question, we also identified that individuals receiving special 
educational support also showed persistently elevated levels of non-psychotic 
symptomatology compared to controls across adolescence and into early adulthood.  
It is important to note that this population was recruited through educational services 
and very few of them had sought medical attention for these symptoms.  Although the 
absolute differences in PANSS scores were relatively small, the impact of having 
morbid psychopathology in adolescents is high (26, 27).  We have previously shown 
that functional outcome in this cohort is highly variable and is related to intellectual 
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ability and behavioural difficulties (28); we did not however consider ongoing 
psychopathology in that report.  The findings presented here suggest that this matter 
merits further attention, as much of the general psychopathology was accounted for 
by anxiety and mood related symptoms, and effective treatments for these symptoms 
are well-established.  The identification and treatment of these symptoms would at 
least relieve distress, and may help to lift those whose functional outcome is limited to 
the very much better levels of some of their peers so that they might reach their full 
potential.   
 
There are a number of potential issues as regards this study which merit further 
consideration.  The defining characteristic of the sample was their receipt of special 
educational assistance due to presumed intellectual impairment, but within the sample 
there was a wide range of educational difficulties reported by families.  Unfortunately 
we did not have access to school records to confirm the exact nature of these reported 
difficulties therefore we were unable to examine whether specific difficulties are 
associated with later mental ill health.  We do not have detailed symptom level data 
for those who did not return for the final follow-up and it is possible that this may 
have biased our results.  However, there were no significant differences in baseline 
SIS/CBCL group membership between those who attended all three time points and 
those who only attended the first two, therefore it is unlikely that this drop-off 
selectively affected our findings.  It is also important to note that the group under 
study here was deliberately sampled to be weighted towards those scoring highly on 
the SIS and CBCL (see Figure 1).  As such the exact rates of psychopathology for the 
group as a whole cannot be generalized to the wider population of people receiving 
educational assistance.  However, even the group of participants who scored below 
21 
 
the cut-offs on both the SIS and the CBCL showed higher levels of psychopathology 
compared to controls (Figure s1 in Supplementary Material), indicating that our broad 
finding of increased psychopathology in this group is likely to hold for the wider 
population.  Finally, although the clinicians rating psychopathology were technically 
blinded as to whether or not a participant was in receipt of educational assistance, in 
many cases this may have become apparent to them during the conduct of the clinical 
interview which could have influenced our findings for the SEN group as a whole; it 
is worth highlighting however that they would have remained unaware of SIS/CBCL 
group membership.   
 
Implications 
Overall, these findings suggest that the personality and behavioural features 
associated with the development of psychosis in those with intellectual impairments 
are similar in nature to those observed in people who are vulnerable to psychosis as a 
result of their familial genetic loading.  They also raise the possibility of using 
relatively simple screening measures to identify those at greatest risk of future 
psychosis, and highlight the need to be vigilant for the presence of potentially 
treatable psychopathology, both of a psychotic and non-psychotic nature, in this 
vulnerable group.    
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Supplementary Material  
Figure s1: PANSS positive, negative and general subscale scores in those with SEN, 
divided into SIS/CBCL groupings, and controls at each timepoint.  
 
PANSS, Positive and Negative Syndrome Scale; SEN, Special Educational Needs; 
SIS, Structured Interview for Schizotypy; CBCL, Childhood Behavioural Checklist.  
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Figures s2-s4: Breakdown of PANSS scores by individual symptoms for the SEN 
group.  
Figure s2  
 
 
 
 
 
Figure s3  
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Figure s4  
 
Y axis represents the percentage of all ratings made for participants throughout the 
study. Darker colours represent the proportion of these ratings which were scores as 3 
or more.  
PANSS, Positive and Negative Syndrome Scale; SEN, special educational needs 
group; TC, typical controls.  
P1 – delusions, P2 – conceptual disorganisation, P3 – hallucinations, P4 – excitement, 
P5 – grandiosity, P6 – suspiciousness, P7 – hostility; N1 – blunted affect, N2 – 
emotional withdrawal, N3 – poor rapport, N4 – passive-apathetic social withdrawal, 
N5 – difficulty in abstract thinking, N6 – lack of spontaneity and flow of conversation, 
N7 – stereotyped thinking; G1 - somatic concern, G2 – anxiety, G3 – guilt, G4 – 
tension, G5 – mannerisms and posturing, G6 – depression, G7 – motor retardation, G8 
– uncooperativeness, G9 – unusual thought content, G10 – disorientation, G11 – poor 
attention, G12 – lack of judgement and insight, G13 – disturbance of volition, G14 – 
poor impulse control, G15 – preoccupation, G16 – active social avoidance  
 
